IMARC Group, a leading market research company, has recently released a report titled “Biopharmaceutical Third Party Logistics (3PL) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global biopharmaceutical third party logistics (3PL) market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

What Are The Growth Prospects Of The Biopharmaceutical Third Party Logistics (3PL) Industry?

According to the report, The global biopharmaceutical third party logistics (3PL) market size reached US$ 116.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 161.7 Billion by 2028, exhibiting a growth rate (CAGR) of 5.6% during 2023-2028.

What is Biopharmaceutical Third Party Logistics (3PL)?

Biopharmaceutical third party logistics (3PL) refers to the transportation of medicines using advanced vehicles. These vehicles are specially designed to automate temperature and reduce the possibility of human errors during transportation. Biopharmaceutical 3PL helps carry various medical products, maintain inventory of the goods and fulfill orders. It also minimizes overhead expenses, ensures uninterrupted product supply and improves the transportation services of an organization.

Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/biopharmaceutical-third-party-logistics-market/requestsample

What are the growth prospects and trends in the Biopharmaceutical Third Party Logistics (3PL) industry?

The rising demand for effective logistics systems to safely transport temperature-sensitive medicines is one of the key factors driving the growth of the global biopharmaceutical 3PL market. Furthermore, the emerging trend of outsourcing logistics by medical organizations to optimize their distribution network is propelling market growth. As coronavirus disease (COVID-19) continues to spread across the globe, there has been a significant increase in the demand for 3PL logistics to minimize drug supply disruptions and prioritize the availability of critical care drugs. Moreover, various technological advancements and growing environmental concerns among pharmaceutical companies to reduce carbon footprint are creating a positive outlook for the market.

Who are the key players operating in the industry?

The report covers the major market players including:

  • Agility Logistics
  • AmerisourceBergen Corporation
  • DB Schenker (Deutsche Bahn)
  • DHL International GmbH (Deutsche Post)
  • FedEx Corporation
  • Kerry Logistics Network Limited
  • Kuehne + Nagel International AG
  • McKesson Corporation
  • SF Express Co. Ltd.
  • United Parcel Service of America Inc.

For more information about this report visit: https://www.imarcgroup.com/biopharmaceutical-third-party-logistics-market

The report has segmented the market on the basis of Product Type, Distribution Channel, Packaging Type and Region.

Breakup by Supply Chain:

  • Cold Chain
  • Non-Cold Chain

Breakup by Service Type:

  • Transportation
    • Air Freight
    • Sea Freight
    • Overland
  • Warehousing and Storage
  • Others

Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Contact US

IMARC Group

Email: [email protected]

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Address: 134 N 4th St. Brooklyn, NY 11249, USA 

Follow us on Twitter: @imarcglobal